GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » PensionAndRetirementBenefit

Boiron (FRA:BON) PensionAndRetirementBenefit : €60.5 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Boiron PensionAndRetirementBenefit?

Boiron's PensionAndRetirementBenefit for the quarter that ended in Dec. 2023 was €60.5 Mil.

Boiron's quarterly PensionAndRetirementBenefit declined from Dec. 2022 (€62.0 Mil) to Jun. 2023 (€61.1 Mil) and declined from Jun. 2023 (€61.1 Mil) to Dec. 2023 (€60.5 Mil).

Boiron's annual PensionAndRetirementBenefit declined from Dec. 2021 (€72.8 Mil) to Dec. 2022 (€62.0 Mil) and declined from Dec. 2022 (€62.0 Mil) to Dec. 2023 (€60.5 Mil).


Boiron PensionAndRetirementBenefit Historical Data

The historical data trend for Boiron's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron PensionAndRetirementBenefit Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 109.76 87.03 72.77 62.02 60.48

Boiron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.77 62.78 62.02 61.08 60.48

Boiron PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Boiron (FRA:BON) Business Description

Industry
Traded in Other Exchanges
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.